{"title":"Pulmonary Vein Reconnection Burden and Extra-Pulmonary Vein Ablation During Second Catheter Ablation for Atrial Fibrillation in the Pre-Pulsed-Field Ablation Era: A Multicenter Registry.","authors":"Yoshimori An, Tetsuma Kawaji, Shushi Nishiwaki, Yasuhiro Sasaki, Junichi Ooka, Kazuto Kujira, Tomoyuki Inoue, Misaki Naka, Akihira Suenaga, Hiroto Tanaka, Shintaro Yamagami, Ryuki Chatani, Tokuma Kawabata, Naoaki Onishi, Takashi Yoshizawa, Satoshi Shizuta, Kyohei Yamaji, Koh Ono, Atsushi Kobori, Kazuaki Kaitani","doi":"10.1111/jce.70558","DOIUrl":"https://doi.org/10.1111/jce.70558","url":null,"abstract":"<p><strong>Background: </strong>Contemporary procedural characteristics of second catheter ablation (CA) for atrial fibrillation (AF) remain incompletely characterized.</p><p><strong>Objective: </strong>To investigate procedural characteristics and clinical implications of pulmonary vein (PV) reconnection during second CA for AF.</p><p><strong>Methods: </strong>We analyzed 854 patients who underwent second CA for AF between April 2021 and March 2024 at nine institutions before the clinical adoption of pulsed-field ablation. Patients were stratified according to the number of reconnected PVs identified during the procedures: none (0), single (1), and multiple (≥ 2). The primary endpoint was freedom from atrial arrhythmia recurrence, assessed using multivariable Cox proportional hazards models.</p><p><strong>Results: </strong>During second CA, PV reconnections (21% per vein) were identified and re-isolated in all affected PVs. Patients with no PV reconnection accounted for 55.5% (n = 474) of the cohort and underwent extra-PV ablation more frequently than those with single (n = 146) or multiple (n = 234) reconnected PVs. During a median follow-up of 706 days, multiple reconnected PVs with subsequent re-isolation were associated with a lower risk of atrial arrhythmia recurrence than no PV reconnection. This association remained significant after multivariable adjustment (hazard ratio 0.69, 95% confidence interval 0.50-0.95; p = 0.023) and was more pronounced in patients without symptomatic heart failure (p for interaction = 0.009). Enlarged left atrial diameter, non-paroxysmal AF, and symptomatic heart failure were also independently associated with recurrence, whereas additional extra-PV ablation was not.</p><p><strong>Conclusion: </strong>Re-isolation of multiple reconnected PVs was independently associated with a lower risk of atrial arrhythmia recurrence after second CA for AF, particularly in patients without symptomatic heart failure.</p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeanne E Poole, Marye J Gleva, Kelley R H Branch, Ulrika Birgersdotter-Green, Rahul N Doshi, Arun R Sridhar, Laura M Gustavson, Shirley A Zulueta, Wayne C Levy
{"title":"Real-World Performance of a Novel Wearable Cardioverter-Defibrillator System: Primary Results From a National Prospective Post-Approval Registry Study (ACE-PAS).","authors":"Jeanne E Poole, Marye J Gleva, Kelley R H Branch, Ulrika Birgersdotter-Green, Rahul N Doshi, Arun R Sridhar, Laura M Gustavson, Shirley A Zulueta, Wayne C Levy","doi":"10.1111/jce.70556","DOIUrl":"https://doi.org/10.1111/jce.70556","url":null,"abstract":"<p><strong>Introduction: </strong>Wearable cardioverter defibrillators (WCDs) protect patients at elevated risk of sudden cardiac death (SCD) but are effective only when worn. The ASSURE WCD was designed to address historical limitations related to false alarms and patient adherence. The objective of this post-approval study was to assess safety and effectiveness in a large, real-world cohort.</p><p><strong>Methods: </strong>The study population was comprised of patients meeting WCD indications who were fitted with the ASSURE WCD. The primary effectiveness endpoint was overall shock conversion success for ventricular tachycardia (VT) or ventricular fibrillation (VF) (performance goal ≥ 89%), and the primary safety endpoint was the incidence of inappropriate shocks (performance goal ≤ 0.0075 per patient-month).</p><p><strong>Results: </strong>Among 21 612 patients (mean age 64.0 years, 33.9% female), median daily use was 23.1 h/day (IQR 16.1-23.9) over 54 days (IQR 20-97). WCD indications included cardiomyopathy (63.8%), post-myocardial infarction (19.3%), sustained VT/VF (11.9%) and ICD explant/other (5.0%). Both primary effectiveness and safety endpoints were met. All 303 VT/VF shock events in 261 patients (1.2%) were successfully converted, yielding an overall shock conversion success of 100% (95% CI: 98.8%-100%), with first-shock success of 97.0% (95% CI: 94.4%-98.5%). The incidence rate of inappropriate shocks was 0.0065 per patient-month (95% CI: 0.0057-0.0073). False-positive alarms occurred in 6.0% of patients. The 90-day Kaplan-Meier estimated risk of VT/VF was 3.4%, varying by WCD indication (p < 0.001) but not by left ventricular ejection fraction (p = 0.16).</p><p><strong>Conclusion: </strong>In routine practice, the ASSURE WCD effectively terminated VT/VF with low false alarm and inappropriate shock rates and high patient adherence. Most VT/VF events occurred early during WCD wear. Collectively, these findings provide important contemporary evidence to inform the selection of patients who may benefit from WCD therapy during periods of elevated arrhythmic risk.</p><p><strong>Trial registration: </strong>NCT05135403.</p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Large Language Model-Based Localization of Premature Ventricular Contraction Origins: A Retrospective Diagnostic Accuracy Study","authors":"Kazuhisa Matsumoto, Yuya Fujisaki, Syunta Higuchi, Masataka Narita, Wataru Sasaki, Tsukasa Naganuma, Naomichi Tanaka, Daisuke Kawano, Kei Matsumoto, Wataru Yoshino, Yoshifumi Ikeda, Ritsushi Kato, Hitoshi Mori","doi":"10.1111/jce.70464","DOIUrl":"10.1111/jce.70464","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Accurate localization of premature ventricular contraction (PVC) origin from 12-lead electrocardiography (ECG) is important for procedural planning in catheter ablation. Although convolutional neural network (CNN)-based models have shown promising diagnostic performance, they require task-specific training and remain limited in interpretability. We evaluated whether large language model (LLM)-based ECG image interpretation could perform binary left-versus-right PVC origin localization from 12-lead ECG images while providing a traceable diagnostic process.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively studied 157 patients who underwent successful catheter ablation of PVCs or idiopathic ventricular tachycardia. ECG images were classified as RIGHT-origin (<i>n</i> = 103) or LEFT-origin (<i>n</i> = 54) according to the final successful ablation site. Three approaches were compared: a CNN-based baseline model, an LLM-based one-shot approach, and an LLM-based staged extraction framework with deterministic rule-based integration. Performance was evaluated across five independent seeds using positive predictive value (PPV), negative predictive value (NPV), recall, and PPV + NPV.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The CNN-based baseline model achieved a PPV of 0.546 ± 0.058 and an NPV of 0.793 ± 0.047, with area under the curve values ranging from 0.595 to 0.730. The staged extraction framework generated a continuous rule-based score with discrimination numerically comparable to the CNN-based model (AUC 0.720 ± 0.045 vs. 0.712 ± 0.054). A stricter threshold, determined from training data, increased PPV at the expense of recall and warrants prospective external validation of this operating point.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>LLM-based staged extraction demonstrated the potential to achieve binary left-versus-right PVC origin localization from 12-lead ECG images while providing a traceable stepwise diagnostic process. The continuous rule-based score showed discrimination numerically comparable to the CNN-based model, and the strict threshold—determined using training data—identified a potential high-PPV operating point that requires prospective external validation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2587-2597"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jce.70464","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148653862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chelsea A. Boyd, Michael A. Bruno, Carlos A. Lodeiro, Duc T. Nguyen, Ankona Banerjee, Alexandra M. Menillo, Tam Dan N. Pham, Christina Y. Miyake, Wilson W. Lam, Bryan C. Cannon, Jeffrey J. Kim, Santiago O. Valdés, Taylor S. Howard
{"title":"Detection of Accessory Pathway Recurrence at Standard and Abbreviated Waiting Periods and Implications for Recurrence Following Pediatric Radiofrequency Ablation","authors":"Chelsea A. Boyd, Michael A. Bruno, Carlos A. Lodeiro, Duc T. Nguyen, Ankona Banerjee, Alexandra M. Menillo, Tam Dan N. Pham, Christina Y. Miyake, Wilson W. Lam, Bryan C. Cannon, Jeffrey J. Kim, Santiago O. Valdés, Taylor S. Howard","doi":"10.1111/jce.70448","DOIUrl":"10.1111/jce.70448","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Despite routine use, the benefit of a post-ablation waiting period (WP) following pediatric radiofrequency (RF) accessory pathway (AP) ablation remains unclear. The incidence of WP recurrence, the optimal WP duration, and the impact of the WP on subsequent recurrence are not well defined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We performed a retrospective study of pediatric patients who underwent acutely successful RF AP ablation from September 2020 to February 2025. Patients with prior ablation, multiple pathways, cryoablation, or additional arrhythmia mechanisms were excluded. A total of 232 patients were included. All underwent 30 min post-ablation WP testing and were monitored for 24 h recurrence on a Holter monitor. Recurrence during follow-up was also assessed. A subset of 104 patients underwent 10 min WP testing in addition to 30 min WP testing. A cumulative procedural risk score (contact issue, difficult pathway characteristics, mechanical trauma, and return of AP conduction after transient effect) was compared between recurrent and non-recurrent pathways, both for WP and follow-up recurrence. Bivariate comparisons and logistic regression were performed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 232 patients (median age 13.0 years), 30 min WP recurrence occurred in 8 patients (3.4%), all with manifest pathways. Detection of WP recurrence resulted in absolute risk reductions (ARR) of 4.3% and 3.0% in 24 h and follow-up recurrence, respectively, among manifest pathways. A 2.2% ARR in follow-up recurrence was observed in the total cohort including concealed pathways. WP recurrence was associated with increased risk of follow-up recurrence (OR 7.3, 95% CI 1.6−33.2, <i>p</i> = 0.01). Among the 104 patients who underwent both 10 and 30 min WPs, four recurrences occurred (3.8%); three of four were detected at 10 min, yielding 75.0% sensitivity and 99.0% negative predictive value for predicting 30 min recurrence. Right free wall AP location (OR 6.9, CI 1.2−39.2, <i>p</i> = 0.03) and the cumulative procedural risk score (OR 4.3, 95% CI 2.0−10.2, <i>p</i> < 0.001) were significantly associated with WP recurrence in univariable analysis. In follow-up (median 3.3 years [IQR 2.1−4.2]), recurrence was detected in 20 patients (8.6% of the total cohort). Congenital heart disease, right free wall AP location, and cumulative procedural risk score were associated with follow-up recurrence, although the association of the risk score with follow-up recurrence was attenuated in multivariable analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Performing a post-ablation WP pro","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2493-2503"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148470747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Identifying Driver Regions in Persistent Atrial Fibrillation: A Mosaic Pattern Within the Atrial Voltage Transition Zone","authors":"Naidong Pang, Zhoubin Cao, Yirao Tao, Yanjiang Wang, Liang Shi, Simeng Deng, Jianjun Zhang, XingPeng Liu","doi":"10.1111/jce.70451","DOIUrl":"10.1111/jce.70451","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aims</h3>\u0000 \u0000 <p>Driver-targeted ablation is a potential adjunct to pulmonary vein isolation (PVI) in persistent atrial fibrillation (PsAF), yet identifying drivers remains challenging. This study investigates whether voltage characteristics can facilitate driver identification.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In a multicenter retrospective exploratory cohort of 201 patients with PsAF undergoing PVI plus driver ablation, voltage characteristics within 241 driver regions were analyzed to derive an optimal voltage transition zone. A prospective validation cohort of 53 patients subsequently underwent ablation guided by this mapping approach.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The optimal voltage threshold (0.16–0.61 mV) captured 78.8% of driver regions, which frequently exhibited a mosaic pattern at the interface of low-, transition-, and normal-voltage areas. This approach outperformed conventional low-voltage area–based identification (42.3%, <i>p</i> = 0.004). Mosaic pattern recognition using two voltage thresholds achieved 94.2% sensitivity and 77.1% specificity. Among cases without acute AF termination, the mosaic pattern was still observed in 87.5% of driver regions. In the validation cohort, acute AF termination (69.8%) and 12-month freedom from atrial arrhythmias were comparable to the exploratory cohort, though freedom from AF was lower (<i>p</i> = 0.035) but AF proportion among recurrences was reduced (<i>p</i> = 0.009). Procedure time and number of drivers ablated were also decreased (<i>p</i> = 0.001 and 0.003, respectively).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This work proposes a hypothesis that AF driver regions in PsAF frequently exhibit a mosaic pattern under optimized voltage thresholds, which may provide a feasible adjunct to electrogram-guided mapping; whether this approach improves clinical outcomes remains to be determined.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2504-2517"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148470755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wojciech Jacheć, Łukasz Tułecki, Dorota Nowosielecka, Andrzej Kutarski
{"title":"Development and Validation of the LIFE-5S Score for Predicting 5-Year Mortality After Transvenous Lead Extraction","authors":"Wojciech Jacheć, Łukasz Tułecki, Dorota Nowosielecka, Andrzej Kutarski","doi":"10.1111/jce.70427","DOIUrl":"10.1111/jce.70427","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Long-term mortality after transvenous lead extraction (TLE) remains substantial despite high procedural success. However, simple tools for estimating long-term prognosis after successful TLE are lacking.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods and Results</h3>\u0000 \u0000 <p>This retrospective multicenter study included 3368 consecutive patients undergoing TLE between 2006 and 2020 with complete 5-year follow-up. Patients were assigned in a 1:1 ratio to derivation and validation cohorts (<i>n</i> = 1684 each). Independent predictors of mortality were identified using multivariable Cox proportional hazards analysis and incorporated into a point-based risk score, the List of Independent Factors for Estimated 5-Year Survival (LIFE-5S).</p>\u0000 \u0000 <p>During follow-up, cumulative 5-year mortality was 32.2%. Independent predictors included male sex, older age, permanent atrial fibrillation, advanced heart failure (NYHA class III/IV), type 2 diabetes, renal dysfunction, reduced left ventricular ejection fraction, pocket infection, lead-related infective endocarditis, and the presence of cardiac resynchronization therapy. Each 1-point increase in the LIFE-5S score was associated with higher mortality risk (HR 1.36, 95% CI 1.33–1.39; <i>p</i> < 0.001). The model demonstrated good discrimination (AUC 0.786 in the derivation cohort and 0.785 in the validation cohort) and good calibration across score strata. To facilitate clinical application, an online calculator based on the LIFE-5S model is available (https://usuwanieelektrod.pl/life5scalculator).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The LIFE-5S score provides a simple bedside tool for long-term prognostic stratification after TLE. This model may support clinical decision-making, patient counseling, and planning of individualized follow-up strategies after TLE.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2452-2464"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148411769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Geoffroy Ditac, Lucas Deville, Rami Mehri, Lai Van Duc, Raphael Martins, Louis Rigal, Clement Boiteux, Francis Bessière, Kevin Gardey, Antoine Delinière, Michael S. Lloyd, Geoffrey D. Hugo, Phillip S. Cuculich, Cliff Robinson, Antoine Simon, Loig Duvergé, Julien Bellec, Charles Guenancia, Sandro Ninni, Frederic Sacher, Josselin Duchateau, Cedric Yvorel, Marouane Boukhris, Antoine Da Costa, Renaud de Crevoisier, Karim Benali
{"title":"Variability and Main Determinants of Planning Target Volume During Cardiac Stereotactic Radioablation for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled Analysis","authors":"Geoffroy Ditac, Lucas Deville, Rami Mehri, Lai Van Duc, Raphael Martins, Louis Rigal, Clement Boiteux, Francis Bessière, Kevin Gardey, Antoine Delinière, Michael S. Lloyd, Geoffrey D. Hugo, Phillip S. Cuculich, Cliff Robinson, Antoine Simon, Loig Duvergé, Julien Bellec, Charles Guenancia, Sandro Ninni, Frederic Sacher, Josselin Duchateau, Cedric Yvorel, Marouane Boukhris, Antoine Da Costa, Renaud de Crevoisier, Karim Benali","doi":"10.1111/jce.70461","DOIUrl":"10.1111/jce.70461","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Cardiac stereotactic arrhythmia radioablation (STAR) has emerged as a promising alternative for patients with refractory ventricular arrhythmias (VAs). However, the absence of recommendations for margin selection may lead to considerable differences in the treatment plan generation between teams.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This systematic review and pooled analysis aimed at determining the inter-study variability in target volumes as well as the main drivers of the final treated volume during STAR for refractory VAs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>MEDLINE and EMBASE databases were searched until January 31, 2025, to identify all studies describing the use of STAR for treating refractory VAs. Treatment volumes were extracted including clinical target volume (CTV), internal target volume (ITV), and planning target volume (PTV). Volume expansion was assessed using PTV/CTV, ITV/CTV and PTV/ITV ratios.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 1020 references were retrieved, of which 13 studies met the inclusion criteria, representing 126 patients treated with STAR for VAs. In aggregates, the pooled total volume expansion (PTV/CTV ratio) was 2.8 (95% CI: 2.0–3.6, <i>I</i><sup>2</sup> = 73%), the pooled volume expansion related to treatment delivery uncertainties (PTV/ITV ratio) was 1.9 (95% CI: 1.7–2.2, <i>I</i><sup>2</sup> = 12%) and the pooled volume expansion related to cardiorespiratory margins (ITV/CTV ratio) was 1.9 (95% CI: 1.4–2.3, <i>I</i><sup>2</sup> = 36.5%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Generation of the treatment volume in STAR for refractory VA is subject to high variability even among expert teams, with a ninefold difference observed between the smallest and largest reported average PTV. Margins related to uncertainties in treatment delivery seem to contribute as much as margins related to cardiorespiratory movement in determining the final treatment volume.</p>\u0000 \u0000 <p><b>PROSPERO registration:</b> CRD42024580242.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2576-2586"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148653899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yurun Shi, Fanxi Xiong, Dan Li, Yue Zhou, Jian Lu, Wenyue Zheng, Yunru Wang, Wenjun Huang, Lin Wu, Miaoling Li
{"title":"Unraveling Sex Disparities of Atrial Fibrillation/Flutter in Asia: Contributions of Lifestyle Factors (Smoking, Excessive Alcohol Intake) and Life Expectancy","authors":"Yurun Shi, Fanxi Xiong, Dan Li, Yue Zhou, Jian Lu, Wenyue Zheng, Yunru Wang, Wenjun Huang, Lin Wu, Miaoling Li","doi":"10.1111/jce.70462","DOIUrl":"10.1111/jce.70462","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The burden of atrial fibrillation/atrial flutter (AF/AFL) continues to increase globally, particularly in rapidly ageing regions such as Asia. However, the contributions of population aging, life expectancy, and lifestyle-related risk factors to sex-specific disparities in AF/AFL burden remain poorly understood.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To investigate sex-specific differences in AF/AFL burden across Asia and evaluate the contributions of population ageing, life expectancy, and modifiable risk factors using Global Burden of Disease (GBD) data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods and Results</h3>\u0000 \u0000 <p>GBD data were used to assess AF/AFL prevalence, incidence, disability-adjusted life years (DALYs), mortality, and attributable risk factors across 34 Asian countries and regions, stratified by sex and age. In 2023, AF/AFL affected 59.10 million individuals worldwide, with Asia accounting for nearly half of the global burden. Prevalence and incidence were consistently higher in males, whereas females, particularly at older ages, experienced a greater burden of DALYs and mortality. Marked heterogeneity was observed across Asian countries. Population ageing emerged as a major driver of AF/AFL burden, with most Asian countries classified as aging or aged societies. Hypertension was the leading attributable risk factor overall, while smoking and excessive alcohol consumption contributed disproportionately to the male burden. Forecasting analyzes projected a continued increase in AF/AFL burden through 2036.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>AF/AFL remains a growing public health challenge across Asia. Although prevalence is higher in males, elderly females bear a disproportionately greater burden of disability and mortality. Population ageing, together with smoking and excessive alcohol consumption in men, may contribute substantially to these sex disparities. Sex- and age-specific prevention and management strategies are needed to reduce the future burden of AF/AFL in Asia.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2552-2564"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148562112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lea Lippert, Tobias Burkard, Franziska Markel, Volker Debus, Fridrike Stute, Anna Kamphues, Robert Dalla Pozza, Stefan Rupp, Maria B. Gonzalez y Gonzalez, Claudia Junge, Majed Kanaan, Kirstin Hoff, Anja Hanser, Sven Dittmann, Dominik Sebastian Westphal, Isabel Diebold, Sebastian Clauß, Stefanie Kessner, Marc-Phillip Hitz, Kolja Becker, Stefan Kääb, Peter Ewert, Michael Hofbeck, Wolfgang Wällisch, Sven Dittrich, Anselm Uebing, Stephan Neumann, Jan-Hendrik Nürnberg, Joachim Hebe, Rainer Kozlik-Feldmann, Philipp Beerbaum, Gunter Kerst, Eric Schulze-Bahr, Roman Gebauer, Gabriele Hessling, Cordula Maria Wolf
{"title":"Brugada Syndrome in the Pediatric Population: Diagnostic Challenges and Clinical Outcome—Results of the German Multicenter Study COGIA","authors":"Lea Lippert, Tobias Burkard, Franziska Markel, Volker Debus, Fridrike Stute, Anna Kamphues, Robert Dalla Pozza, Stefan Rupp, Maria B. Gonzalez y Gonzalez, Claudia Junge, Majed Kanaan, Kirstin Hoff, Anja Hanser, Sven Dittmann, Dominik Sebastian Westphal, Isabel Diebold, Sebastian Clauß, Stefanie Kessner, Marc-Phillip Hitz, Kolja Becker, Stefan Kääb, Peter Ewert, Michael Hofbeck, Wolfgang Wällisch, Sven Dittrich, Anselm Uebing, Stephan Neumann, Jan-Hendrik Nürnberg, Joachim Hebe, Rainer Kozlik-Feldmann, Philipp Beerbaum, Gunter Kerst, Eric Schulze-Bahr, Roman Gebauer, Gabriele Hessling, Cordula Maria Wolf","doi":"10.1111/jce.70484","DOIUrl":"10.1111/jce.70484","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Diagnosis and treatment of children and adolescents with suspected Brugada syndrome (BrS) is challenging. Aim of the study was to evaluate the applicability of current diagnostic criteria for pediatric patients with suspected BrS in the German multicenter study COGIA and to assess clinical outcome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data analysis of 76 pediatric patients from 12 German tertiary care centers. Primary outcome was defined by the occurrence of a major arrhythmic event (MAE), secondary outcome by symptoms, pharmacotherapy and implantation of devices. MAE was defined as sudden cardiac death (SCD), aborted cardiac arrest (ACA) and appropriate implantable cardioverter-defibrillator (ICD) therapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Criteria for BrS diagnosis were fulfilled in 39/76 pediatric patients (51.3%) according to ESC Guidelines, including 34 patients (44.7%) according to Shanghai Score. Genetic testing identified a (likely) pathogenic <i>SCN5A</i> variant in 31/66 tested children (47.0%) (14/30 with clinical diagnosis (46.7%) and 17/36 without clinical diagnosis (47.2%)). Twenty-four patients (31.6%) showed a spontaneous type 1 ECG pattern, in 6 patients (7.9%) it was induced by fever. Ajmaline challenge was positive in 19/25 patients (76.0%). Syncope occurred in 15 patients (19.7%) and an ICD was implanted in 7 pediatric patients (9.2%). Four patients (5.3%) experienced a MAE (ACA), all of them fulfilling diagnostic criteria. “Symptoms at first consultation” was identified as an independent risk factor for MAE in the whole cohort (HR = 11.3, <i>p</i> = 0.04).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Establishing the diagnosis of BrS remains challenging in the pediatric cohort. MAE occurred in 5.3% of patients with suspected BrS. Symptoms at first consultation increased risk for MAE.</p>\u0000 \u0000 <p><b>Clinical Trial Registration:</b> The study is registered at the German Clinical Trial Register (DRKS) of the Federal Institute for Drugs and Medical Devices (BfArM), DRKS-ID DRKS00028138.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":"2638-2650"},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jce.70484","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148860243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cover Image, Volume 37, Issue 11","authors":"Thai Duy Vo, Ting-Yung Chang, Chin-Yu Lin, Pei-Yi Wang, Kuo-Hsiang Lu, Hsin-Lei Huang","doi":"10.1111/jce.70563","DOIUrl":"https://doi.org/10.1111/jce.70563","url":null,"abstract":"<p>The cover image is based on the article <i>Differential Air Entrainment of Mini-Basket and Circular Mapping Catheters Through the FARADRIVE Sheath: Mitigation With a Liquid-Sealed Insertion Method</i> by Thai Duy Vo et al., https://doi.org/10.1111/jce.70492.\u0000\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":"37 11","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jce.70563","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}